The global direct-to-consumer laboratory testing market size accounted for USD 3.44 billion in 2024, grew to USD 3.75 billion in 2025 and is predicted to surpass around USD 8.07 billion by 2034, representing a healthy CAGR of 8.90% between 2024 and 2034. The North America direct-to-consumer laboratory testing market size is calculated at USD 1.62 billion in 2024 and is expected to grow at a fastest CAGR of 8.96% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Direct-to-Consumer Laboratory Testing Market, by Product, 2024-2034
8.1.1 Medical Genetic Laboratory Testing
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Routine Clinical Laboratory Testing
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Direct-to-Consumer Laboratory Testing Market, by Test Type, 2024-2034
9.1.1. Genetic Testing
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. COVID-19
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Cancer
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Diabetes Testing
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Disease Risk Assessment Testing
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Sexually Transmitted Disease Testing
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Routine Testing
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.8. Complete Blood Count
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Complete Blood Count
9.1.9.1. Market Revenue and Forecast (2021-2034)
9.1.10. Thyroid Stimulating Hormone Testing
9.1.10.1. Market Revenue and Forecast (2021-2034)
9.1.11. Other
9.1.11.1. Market Revenue and Forecast (2021-2034)
10.1. Direct-to-Consumer Laboratory Testing Market, by Sample Type, 2024-2034
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Urine
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Saliva
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Sample Type (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Test Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Sample Type (2021-2034)
12.1. 23andMe, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ambry Genetics Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ancestry.com LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Any Lab Test Now, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Color Genomics, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Counsyl, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. DanteLabs Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Direct Laboratory Services, LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Eastern Biotech & Life Sciences
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. EasyDNA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample